Template:Herpes antiviral treatment: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
====Initial Episode<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>====
====Initial Episode<ref name="a">Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>====
*[[Acyclovir]] OR
*[[Acyclovir]] OR
**400mg PO q8hrs x 7-10 days
**400mg PO q8hrs x 7-10 days
Line 6: Line 6:
*[[Famciclovir]] 250mg PO q8hrs x 7-10 days
*[[Famciclovir]] 250mg PO q8hrs x 7-10 days


====Recurrence<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>====
====Recurrence<ref name="a" />====
*[[Acyclovir]] OR
*[[Acyclovir]] OR
**400mg PO q8hrs x 5 days
**400mg PO q8hrs x 5 days
Line 19: Line 19:
**''or'' 500mg PO once, followed by 250mg PO q12hrs for 2 days
**''or'' 500mg PO once, followed by 250mg PO q12hrs for 2 days


====Suppressive Therapy<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>====
====Suppressive Therapy<ref name="a" />====
*[[Acyclovir]] 400mg PO q12hrs daily OR
*[[Acyclovir]] 400mg PO q12hrs daily OR
*[[Famciclovir]] 250mg PO q12hrs daily OR
*[[Famciclovir]] 250mg PO q12hrs daily OR
*[[Valacyclovir]] 500mg-1g PO daily (500mg may be less effective)
*[[Valacyclovir]] 500mg-1g PO daily (500mg may be less effective)

Revision as of 06:58, 5 June 2015

Initial Episode[1]

Recurrence[1]

  • Acyclovir OR
    • 400mg PO q8hrs x 5 days
    • or 800mg PO q12hrs x 5 days
    • or 800mg PO q8hrs x 2 days
  • Valacyclovir OR
    • 500mg PO q12hrs x 3 days
    • or 1g PO qd x 5 days
  • Famciclovir
    • 125mg PO q12hrs for 5 days
    • or 1g PO q12hrs for 1 day
    • or 500mg PO once, followed by 250mg PO q12hrs for 2 days

Suppressive Therapy[1]

  1. 1.0 1.1 1.2 Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.